_    ___ ___      _                               
/ \ |_ _/ _ \ ___| |_ _ __ ___ __ _ _ __ ___ ___
/ _ \ | | | | / __| __| '__/ _ \/ _` | '_ ` _ \/ __|
/ ___ \ | | |_| \__ \ |_| | | __/ (_| | | | | | \__ \
/_/ \_\___\___/|___/\__|_| \___|\__,_|_| |_| |_|___/
Twitch
Invidious (YT)

Invidious > Channel > verapamil07

Trending
verapamil07 218 subscribers    RSS
View channel on YouTube
Videos
Playlists

YT 16 minutes 56 seconds
U.S. Food and Drug Administration
Orange Book: 101 An Overview (11of27) Generic Drugs Forum 2018
YT 46 minutes
U.S. Food and Drug Administration
Introduction to Investigational New Drug (IND) Applications (3/14) REdI 2017
YT 4 minutes 12 seconds
U.S. Food and Drug Administration
The Basics of Biosimilars
YT 29 minutes 45 seconds
U.S. Food and Drug Administration
Post-Approval Submission of Promotional Materials to the OPDP - REdI 2020
YT 58 minutes 43 seconds
U.S. Food and Drug Administration
So, Your NDA Was Approved – Now What?! Post-approval Responsibilities and Obligations- REdI 2020
YT 58 minutes 49 seconds
Duke University School of Medicine
Investigational New Drug Application (IND) Forms: Updates and Best Practices
YT 1 hour 19 minutes 35 seconds
U.S. Food and Drug Administration
Chemistry, Manufacturing, and Controls (CMC) for an IND (7of14) REdI 2018
YT 1 hour 31 minutes 6 seconds
GlobalCompliance Panel
The FDA Drug Development Process: GLP, GMP and GCP Regulations
YT 1 hour 50 seconds
U.S. Food and Drug Administration
CDER FDA Exclusivity – Which One Is for Me? - June 10, 2019
YT 34 minutes 20 seconds
U.S. Food and Drug Administration
A Medical Officer’s Approach to NDA/BLA Review (8of15) REdI Annual Conference – May 29-30, 2019
YT 41 minutes 30 seconds
U.S. Food and Drug Administration
Meetings: Pre-submission and Special Programs (4of15) REdI Annual Conference – May 29-30, 2019
YT 45 minutes 22 seconds
U.S. Food and Drug Administration
Application Case Studies on FDA’s Action Letter Timing (16of16) GDF 2020
YT 5 minutes 20 seconds
U.S. Food and Drug Administration
Data Requirements for Biosimilars
YT 1 second

[Private video]
YT 21 minutes 6 seconds
European Medicines Agency
Quality aspects in investigational medicinal product developments
YT 1 hour 6 minutes 44 seconds
European Medicines Agency
Module 05 - Clinical trials in the EU
YT 1 hour 11 minutes 26 seconds
European Medicines Agency
Module 01 - Setting the scene: introduction to the EU regulatory network
YT 1 hour 13 minutes 29 seconds
European Medicines Agency
Module 04 - ATMPs
YT 31 minutes 50 seconds
inglasia pharma solutions
An Introduction to Good Manufacturing Practice - Pharmaceutical and Biotechnology Industry
YT 1 hour 12 minutes 3 seconds
Compliance Insight
21 CFR, Parts 210 and 211